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Abstract
Background: Previous research indicates that people with osteoarthritis (OA) are not receiving the recommended and
optimal treatment. Based on international treatment recommendations for hip and knee OA and previous research, the
SAMBA model for integrated OA care in Norwegian primary health care has been developed. The model includes
physiotherapist (PT) led patient OA education sessions and an exercise programme lasting 8–12 weeks. This study aims
to assess the effectiveness, feasibility, and costs of a tailored strategy to implement the SAMBA model.
Methods/design: A cluster randomized controlled trial with stepped wedge design including an effect, process, and
cost evaluation will be conducted in six municipalities (clusters) in Norway. The municipalities will be randomized for
time of crossover from current usual care to the implementation of the SAMBA model by a tailored strategy. The
tailored strategy includes interactive workshops for general practitioners (GPs) and PTs in primary care covering the
SAMBA model for integrated OA care, educational material, educational outreach visits, feedback, and reminder
material. Outcomes will be measured at the patient, GP, and PT levels using self-report, semi-structured interviews, and
register based data. The primary outcome measure is patient-reported quality of care (OsteoArthritis Quality Indicator
questionnaire) at 6-month follow-up. Secondary outcomes include referrals to PT, imaging, and referrals to the
orthopaedic surgeon as well as participants’ treatment satisfaction, symptoms, physical activity level, body weight, and
self-reported and measured lower limb function. The actual exposure to the tailor made implementation strategy and
user experiences will be measured in a process evaluation. In the economic evaluation, the difference in costs of usual
OA care and the SAMBA model for integrated OA care will be compared with the difference in health outcomes and
reported by the incremental cost-effectiveness ratio (ICER).
Discussion: The results from the present study will add to the current knowledge on tailored strategies, which aims to
improve the uptake of evidence-based OA care recommendations and improve the quality of OA care in primary
health care. The new knowledge can be used in national and international initiatives designed to improve the quality
of OA care.
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Background
Osteoarthritis (OA) is a joint disease characterized by
pain, disability, and impaired quality of life. The OA
prevalence increases with age and is growing due to the
aging of the population and the epidemic of obesity [1].
OA is one of the leading causes of pain and disability for
the adult population worldwide [2] and is one of the major
contributors to years lived with disability [3]. The costs of
treatment and work-related losses are a considerable
economic burden [4]. Knee and hip joint replacements for
treatment of advanced OA represent a common inpatient
surgery. Due to the growing obesity epidemic coupled
with aging of the population, the demand for these proce-
dures is expected to accelerate and quadruple by 2030 [5].
Internationally, evidence-based recommendations and
standards of care have been developed to improve OA
management [2, 6–8]. There is currently no known
cure for OA, but non-pharmacological modalities like
education, exercise, and weight reduction represent
core interventions [2]. The recent national recommen-
dation for imaging in musculoskeletal diseases in gen-
eral practice recommends conventional radiographs
and not magnetic resonance imaging (MRI) in decisions
on indication for joint arthroplasty [9]. However, Nor-
wegian and international research indicate that an over-
all increased access to MRI will result in an increased
number of MRI referrals [10], probably also in people
with OA.
Structured approaches and stepped care strategies for
OA management in order to endorse quality of OA
care have been developed in other countries. While
Porcheret et al. developed a stepped care strategy for
older adults in primary care with knee pain or knee OA
[11], the Dutch stepped care strategy (Beating osteo-
ARThritis (BART)) provided a framework for health
care providers and people with hip or knee OA to
discuss the optimal timing of the various treatment op-
tions [12–14]. In the UK MOSAICS study, practice
nurses have been trained to provide OA consultations
and follow-ups and coordinate referrals to the multidis-
ciplinary care [15]. In Australia, initiatives to reduce
the surgery waiting list have been implemented, for
example the Osteoarthritis Chronic Care Program
(OACCP) in New South Wales. In this programme, a
new model of care is being tested, in which a musculo-
skeletal coordinator assesses individuals and links them
with relevant health care providers to support timely
and effective care [16]. During 2008, a Swedish project
called ‘Better management of patients with OsteoArth-
ritis’ (BOA) was initiated to improve OA care and re-
duce sick leave among people with OA [17]. The aim of
BOA is to offer evidence-based OA information and exer-
cise according to treatment recommendations [2, 6–8]
and that surgical interventions should only be considered
if non-surgical treatment has been tried and failed. In
2013, a similar project was started in Denmark ‘Good Life
with Arthritis in Denmark’ (GLA:D) [18]. Although the
health care systems and the models of OA care are some-
what different across countries, the recommendations in
the various national and international guidelines are very
similar. Thus, aspects of these approaches are likely to be
applicable also for other countries.
In the new health sector reform, the Norwegian Director-
ate of Health has placed the main responsibility for OA
treatment in primary health care [19]. However, recent
Norwegian research has indicated that people with OA are
not receiving the recommended and optimal treatment [20,
21]. This was particularly evident for receipt of OA infor-
mation, guidance on lifestyle changes, self-management,
and weight management. Previous research in general prac-
tice has revealed that general practitioners (GPs) are reluc-
tant to discuss weight issues with their patients [22]. A
British study on OA monitoring among GPs revealed that
the GPs favoured monitoring physical function, pain,
and analgesia use over body mass index (BMI), self-
management plans, and exercise advice [23]. The
authors suggested that the provision of suboptimal care
did not result from lack of knowledge and that inter-
ventions to improve OA care must address barriers to
GPs engaging in optimal care provision [23]. A study
among Norwegian physiotherapists (PTs) in private
practice showed that exercise treatment was frequently
provided but also revealed that the PTs also provided
several other treatment modalities with moderate to
low quality of evidence or with no evidence from sys-
tematic reviews [24].
While good communication is an important element
of health care quality, the GP consultation has a
limited duration. This implies a challenge for the GPs
with respect to patient communication and restricts
the amount of information and guidance that can be
included within a short consultation. Current OA
Østerås et al. Implementation Science  (2015) 10:165 Page 2 of 12
guidelines recommend physical activity and a healthy
lifestyle [2, 6–8]. However, behavioural changes are hard
to achieve, and long-term follow-up may be needed. To
support for behavioural changes and self-management is a
challenge within a GP consultation. A recent systematic
review showed that organized follow-up on change of
health behaviour can lead to increased level of physical
activity [25]. Apart from private physiotherapy, there
have up until recently been few other kinds of services
that people with OA can be referred to. Frisklivssentral
(FLS) (Healthy Living Centre) is a relatively new Norwe-
gian primary health care service that aims to guide and
support health-related behavioural changes for individ-
uals with increased risk of, or those who already have, a
disease or illness [26]. PTs represent the majority of em-
ployees at FLS, but people with other professions may
also work at FLS [27]. Close to half of the Norwegian
municipalities had established FLSs by 2014. Earmarked
subsidies are granted and other incentives for further
development are present [28].
Based on international recommendations for OA care
and previous research, the SAMBA model for integrated
care for people with hip and/or knee OA in Norwegian
primary health care has been developed (Additional file 1)
and will be implemented in this study. The purpose of the
model is to improve quality of OA care in primary health
care services by implementing evidence-based inter-
national recommendations for OA care among GPs and
PTs. An implementation of the model should ensure the
provision of optimal, high-quality treatment, and that GPs
and PTs deliver the same consistent message to people
with OA. However, according to previous research, imple-
menting new care models is challenging, and a systematic
review highlighted that there are ‘no magic bullets’ for im-
proving quality of health care [29], but identifying barriers
and enablers of implementing guidelines can guide the se-
lection of more effective implementation strategies that
are tailored to address those determinants [30].
The barriers and facilitators may be different at differ-
ent levels of health care [31]. Grol & Wensing have sug-
gested to categorize barriers to and incentives for
change among health care professionals into awareness,
knowledge, attitude, motivation to change, and behav-
ioural routines [31]. For patients, knowledge, skills, atti-
tude, and compliance are examples of barriers to and
incentives for change. Further, barriers and facilitators at
the social, organizational, economic, and political con-
text may be present as well [31]. According to Sanders
et al., one key obstacle for a successful implementation
in primary care may be to achieve ‘coherence’ of the
desired practice change with the GPs [32]. GPs may not
be able to overcome the inertia of previous practice, may
not have the motivation to change, or may not recognize
the new approach as distinct from usual practice [33, 34].
Among determinants of guideline use among PTs in pri-
mary were care lack of time, poor availability, and limited
access to evidence the most important barriers, whereas
awareness of and positive attitudes towards guidelines and
evidence-based practice, considering guidelines to facili-
tate practice, and knowing how to integrate patient prefer-
ences with guidelines were associated with frequent use of
guidelines [35]. In a recent publication, it is stated that
one of the major barriers to implement effective manage-
ment in OA care is suboptimal patient adherence with
aspects of the management programme [36].
Interventions tailored to prospectively identified barriers
are more likely to improve professional practice than no
intervention or dissemination of guidelines or educational
materials [37]. Previous research has showed that success-
ful guideline implementation strategies should be multifa-
ceted and actively engage clinicians throughout the
process [38]. To identify barriers and facilitators for our
OA care model, we performed three focus groups with
eight GPs, six PTs, and three patient representatives, re-
spectively (Additional file 2). Based on these discussions,
we developed an implementation strategy tailored to the
barriers and facilitators identified by the focus group par-
ticipants (Table 1). The protocol has been reported using
the SPIRIT recommendations and the CONSORT guide-
lines for non-pharmacological interventions [39, 40].
Objective
The main aim of the present study is to assess the effect-
iveness, feasibility, and costs of a tailored strategy to im-
plement the SAMBA model for integrated OA care in
primary health care in Norway.
Hypotheses
A priori, we hypothesize that the tailored strategy for
implementing the SAMBA model for integrated OA care
in a primary care setting will:
 Result in higher quality of care than in current OA
care (higher compliance with treatment
recommendations [2, 6–8] measured by patient-
reported achievement of process quality indicators
in OA care [20])
 Result in more GP referrals to FLS/physiotherapy
and more discharge reports from FLS/PTs to
referring GPs than in current OA care
 Result in less GP referrals to MRI for participants
with OA and less GP referrals to orthopaedic
surgeons in secondary care that does not lead to
scheduled joint surgery
 Result in higher patient satisfaction with the new
OA care model than in current OA care
 Be more effective than current OA care in improving
lifestyle changes (e.g. increase the proportion of
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Table 1 Multifaceted implementation activities to facilitate the implementation of the SAMBA model for integrated OA care
Target group Barrier Activity Description
Patients Awareness, knowledge,
preference
Education material All patients receive an OA booklet from the PT with
information about OA, treatment, and self-management.
Awareness, knowledge,
compliance
Reminder material, exercise diary Together with the electronic questionnaire at 3 months, a
check-list of recommended OA care will be provided. The
patients are asked to keep an exercise diary to register each
session.
Accessibility, availability Direct access to FLS and PT in
private practice, geographically
spread PT locations
The PTs working at FLS or in private practice will be asked
to prioritize the SAMBA patients by ensuring a quick initial
assessment and enrolment in the OA programme.
Availability will be ensured by recruiting PTs working at
different geographical locations.
General
practitioners
Awareness, knowledge, attitude,
motivation to change, and
behavioural routines
Workshop (provision of
information)
The GPs will receive oral and written information on
recommended OA care, the PT treatment programme,
imaging modalities in OA, and information about the
appropriate time to refer to an orthopaedic surgeon.
The workshop will be embedded in existing GP
meetings, be interactive, and allow time for discussions.
SAMBA will be presented as a useful ‘tool’. The PTs will
be invited to the GP workshop and vice versa in order
to know more about each others’ role in OA care.
Awareness, knowledge Education material The GPs will receive a summary of international
guidelines for OA care.
Awareness, knowledge, attitude,
motivation to change, and
behavioural routines
Education outreach visits All general practice clinics will be visited twice during
the intervention period. Each clinic will receive a
reminder call quarterly by the project coordinator.
Awareness Reminder material Posters, pens, post-it note pads, and mouse mats will be
distributed during the workshop.
Motivation to change Opinion leaders/endorsement Local opinion leaders will be identified and asked to
promote the intervention among their colleagues. The GPs’
association will be asked to endorse the SAMBA model.
Awareness, motivation to change Feedback, audit Study newsletters will be distributed 3 times a year.
Feedback on recruitment rate will be included.
Accessibility, attitude, behavioural
change
Direct access to FLS and PT in
private practice
The PT working at FLS or in private practice will be
asked to prioritize the SAMBA patients by ensuring a
quick initial assessment and enrolment in the OA
programme.
Physiotherapists at
FLS and in private
practice
Awareness, knowledge, attitude,
motivation to change and
behavioural routines
Workshop (provision of
information)
The PTs will be educated in delivering OA care in
accordance with clinical guidelines with a standardized
patient education material and exercise programme
recommendations for patients with OA symptoms
primarily from the hip or knee + how to adapt the
standard modes of delivery to the needs of the
individual OA patient. The PTs will be invited to the GP
workshop and vice versa in order to know more about
each others’ role in OA care.
Awareness, knowledge Education material The PTs will receive a summary of international
guidelines for non-pharmacological OA care.
Awareness, knowledge, attitude,
motivation to change, and
behavioural routines
Education outreach visits All FLSs and private PT practices will be visited twice
during the intervention period. Each clinic will receive a
follow-up call quarterly by the project coordinator.
Awareness Reminder material Posters, pens, and post-it note pads will be distributed
during the workshop.
Motivation to change Feedback, audit Study newsletters will be distributed 3 times a year.
Awareness, motivation to change Endorsement, continuing
educational points
The Norwegian Physiotherapist Association will be asked
to endorse the ActiveA programme and to provide
accreditation of the workshop for continuing educational
points.
*Dark cells represent intervention periods, and blank cells represent control periods. The inclusion of patients will start on January 15th 2015 and end on June
15th 2016. The last six month follow-up will be in December 2016 and the last 12-month follow-up will be in June 2017
# The 6 municipalities will switch from control phase to intervention phase in a randomized order
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people with OA that meet the American College of
Sports Medicine’s recommendations for physical
activity and reduce the proportion of people with OA
that are overweight)
Methods/design
Study design
In order to implement the model and to assess the
effects of the tailored strategy, a stepped wedge cluster
randomized controlled trial will be conducted [41]. The
GPs and the PTs in the six participating municipalities
(clusters) in Øvre Romerike will switch from control
(current OA care) to intervention (implementation of
the SAMBA model for integrated OA care) phase in a
randomized order. All municipalities start the trial sim-
ultaneously and act as controls until the point in time
they are randomized to crossover from the control to
the intervention phase, and all municipalities have im-
plemented the SAMBA model for OA care by the end
of the inclusion period (Fig. 1).
Setting
The study will be conducted in six neighbouring muni-
cipalities north of Oslo (Eidsvoll, Gjerdrum, Nannestad,
Hurdal, Ullensaker, and Nes) in collaboration with the
regional hospital (Department of Orthopaedic Surgery
at Akershus University Hospital), the Department of
General Practice at Oslo University Hospital, and Na-
tional Advisory Unit on Rehabilitation in Rheumatology
at Diakonhjemmet Hospital.
Randomization and blinding
The municipalities will be randomly allocated to one of the
six sequences for time of crossover from control to
intervention (implementation) phase using a computer-
generated list of random numbers. Since the number of in-
habitants in the six municipalities varies, stratification on
the number of inhabitants less than versus more than
20,000 will be performed to ensure a mix of municipality
sizes in the randomized sequence. The allocation sequence
will be provided by a statistician. Due to the nature of the
implementation strategy, it is not possible to blind the in-
volved GPs and PTs, but the research coordinator perform-
ing the telephone interviews will remain blinded. Statistical
analyses of primary and secondary outcomes will be per-
formed by the primary investigator and the statistician
blinded for group allocation.
The control phase
During the control phase, the GPs and the PTs receive no
activities to promote the use of the SAMBA model for
integrated OA care or any other facilitation towards an
uptake of the guideline recommendations for OA treat-
ment. Participants with hip and/or knee OA included dur-
ing the control phase may receive physical therapy as
usual, but not the patient education programme, the OA
information booklet, exercise diary, or any of the other
‘activities’ in the SAMBA model for integrated OA care
prior to 12 months post-baseline.
The intervention phase (tailored implementation strategy)
Interactive workshops for GPs and PTs will be arranged
in the six municipalities successively in close proximity
to the time point when they switch from the control to
the intervention period. After the workshops, the GPs
and PTs will implement the SAMBA model for inte-
grated OA care, which include (1) initial GP consult-
ation; (2) psychotherapist (PT) treatment consisting of
3-h OA patient education programme and 8–12 weeks
supervised exercise programme; and (3) GP review
No. 1#
No. 2
No. 3
No. 4
No. 5
No. 6
Year 2014 2015 2017 2018
Quartile 2 3 4 1 4 1 2 3 4 1
Analyses and reporting
Preparation of the trial
Baseline measurements
Follow-up,  process and cost measurements
2 3 4 1 2 3
2016
Cluster randomised stepped wedge tailored implementation* 
Fig. 1 Timeline for the SAMBA project. *Dark cells represent intervention periods, and blank cells represent control periods. The inclusion of
patients will start on January 15th 2015 and end on June 15th 2016. The last six month follow-up will be in December 2016 and the last
12-month follow-up will be in June 2017. #The 6 municipalities will switch from control phase to intervention phase in a randomized order
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consultation followed by self care or a new PT referral
or a referral to an orthopaedic surgeon (see Additional
file 1).
The GP workshop training package
The principal investigator will be responsible for the GP
workshops together with the study coordinator, members
of the project group, and two orthopaedic surgeons from
the regional hospital, Akershus University Hospital. PT
representatives will be invited to attend the GP workshop.
The GP workshop will last about 1.5 h and consist of
three parts: (1) a summary of international evidence-based
recommendations for OA care; (2) an introduction to the
SAMBA intervention; (3) a presentation by an ortho-
paedic surgeon on surgical treatment that is provided, the
appropriate time to refer people with OA for assessment
of surgical treatment, and what kinds of treatment (non-
surgical) or other assessments (conventional radiographs)
that should have been provided before a referral. The
presentation is followed by a discussion with the GPs
regarding the timing and the content of referrals for as-
sessment of surgical treatment.
The PT workshop training package
The PTs will attend a 1-day workshop-based education
programme as part of the ‘Active life with osteoArthritis’
(ActiveA) programme, which is a Norwegian initiative
similar to the Swedish BOA [17] (http/:utv.boaregis-
tret.se) and the Danish GLA:D [18] (http/:glaid.dk). The
ActiveA programme has been developed and is currently
undertaken as collaboration between researchers at Oslo
University Hospital and Diakonhjemmet Hospital, Oslo
(see Additional file 3 and www.aktivmedartrose.no).
The PT workshop includes education in delivering OA
care in accordance with clinical guidelines in a standard-
ized, evidence-based intervention. Education about
healthy nutrition and weight reduction will also be in-
cluded in the workshop. The PTs will receive a complete
patient OA education programme (PowerPoint file) to
use in their clinical setting as well as a selection of
suggested exercises. Furthermore, the PTs will receive
information and instructions regarding the SAMBA
model for integrated OA care.
Recruitment of GPs and PTs
GPs and PTs working in private institutes or at FLSs will
be invited during outreach visits to each practice and
clinic. We aim to recruit 26 (30 %) of the GPs (currently
80 GPs), all PTs (currently 8) at the six FLSs, and 35
(50 %) of the PTs in private practice (currently 70 PTs). In
order to facilitate a high attendance among the GPs, the
project group will preferably use one of the regular, estab-
lished meetings in each municipality for the workshop.
Recruitment of participants with hip and/or knee OA
Participants will be recruited among individuals that visit
their GP with activity-related hip or knee pain/com-
plaints. The GPs will identify eligible people with hip
and/or knee OA, hand out a single-paged information
sheet about the study, and ask for permission for giving
the project group their name and phone number. For
those who agree, their name and phone number are then
mailed by the GP or their secretary in prepaid envelopes
to the project group for further contact. The project
coordinators will then provide study information by
telephone and perform a screening in relation to the
inclusion and exclusion criteria (Table 2). Those that
comply with the criteria will receive the written informa-
tion material and consent form and have 2–3 days to
decide if they want to participate in the study.
A computer programme for identifying eligible people
with hip and/or knee OA will be developed. The GP or
their secretary may run the programme once a month in
order to get a list of patients. This list includes patients
that have consulted their GP in the last 30 days and are
registered with the following International Classification
of Primary Care (ICPC) codes in the past 2 years: L89
(OA of the hip), L90 (OA of the knee), L91 (OA not clas-
sified elsewhere), L13 (hip symptoms/complaints), L 15
(knee symptoms/complaints), or L20 (joint symptoms/
complaints not classified elsewhere). The programme
excludes people registered with ICPC codes L88 (rheuma-
toid arthritis), T92 (gout), and P70 (dementia). When the
GP identify eligible people appearing on this list who were
not informed about the SAMBA study during their
consultation, a letter will be sent from the GP asking the
individuals for permission to be contacted by the study
coordinator. Information leaflets and wall posters in the
GP waiting rooms as well as newspaper articles and infor-
mation at local meetings in the Norwegian Rheumatism
Association can raise awareness of the study so that the
individuals can ask their GP about it. In addition, the PTs
at FLS and in private practice will be instructed to ask
recently referred people with OA if they have received a
request to participate in the SAMBA study.
Sample size calculations
Previous research in the ‘Musculoskeletal pain in Ullensa-
ker Study’ showed that about 12 % of the adult population
self-reported OA in their hip and/or knee joints. Among
these, 89 % visited their GPs in the previous year. The
estimated adult population (aged 40–70) in the six munici-
palities in Øvre Romerike is about 35 000, of which about
4200 might have hip and/or knee OA and 3700 might visit
their GP during a 1-year period. Based on results from a
study in 2012 among 1052 members of the Norwegian
Rheumatism Association with hip and/or knee OA, we
have estimated the intraclass correlation coefficient (ICC)
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(using the 19 counties as clusters) to be <0.01. Further, we
have estimated that a minimum of 194 individuals in each
group among the six clusters with an average of 50 individ-
uals per cluster, achieves 80 % power to detect a 10-unit
difference between the group means of the primary
outcome measure (OsteoArthritis Quality Indicator ques-
tionnaire); when the standard deviation for the primary out-
come measure is 24 units, the drop-out rate is 30 %, and
the intraclass correlation is 0.01, using a two-sided test with
a significance level of 0.05. Hence, we aim to include at
least 388 individuals in total.
The primary outcome measure
The participants with hip and/or knee OA will self-
report the primary outcome measure, as well as most
secondary outcome measures, at five time points: base-
line (shortly after the GP consultation) and then 3-
monthly (Table 3). The primary outcome will be patient-
reported quality of OA care as measured by the Osteo-
Arthritis Quality Indicator questionnaire, a 17-item
questionnaire that includes quality indicators (QIs)
related to OA patient education and information, regular
provider assessments, referrals, and pharmacological
treatment [20]. The items were developed from a litera-
ture review of published QIs, expert panels, and patient
interviews. The patient self-report questionnaire covers
one A4 page with yes/no and ‘not applicable’/‘don’t
remember’ as response options, and a previous applica-
tion has showed acceptable validity and reliability in an
OA cohort [20]. The total QI pass rate for each person
will be calculated as the total number of QIs they
passed, divided by the total number of QIs for which
they were eligible. At inclusion, the primary outcome
measure may be used to assess the effect of the interven-
tion of the GP consultation, whereas at follow-up, it may
be used to assess the total effect of the new model.
Secondary outcome measures
Secondary outcomes will include both process and effect
evaluation measures reported by the participants with
OA, the GPs, and the PTs as well as data obtained from
registers (Table 3). The number of ‘responders’ in the two
groups will be compared using the OMERACT-OARSI
responder criteria [42]. A participant will be classified as a
responder if one of the following is fulfilled:
1) High improvement in pain or function
 ≥50 % improvement + absolute change of ≥2 in
self-reported pain (numeric rating scale (NRS),
0–10), OR
 ≥50 % improvement + absolute change of ≥2 in
self-reported function (NRS, 0–10)
2) Improvement in at least two of the three following:
 ≥20 % improvement + absolute change ≥1 in self-
reported pain (NRS, 0–10)
 ≥20 % improvement + absolute change ≥1 in
patient global assessment of disease activity (NRS,
0–10)
 ≥20 % improvement + absolute change ≥1 in self-
reported function (NRS, 0–10)
Only participants recruited during the intervention
phase will keep an exercise diary. Their attendance at
patient OA education sessions, exercise sessions
(group/ individual), healthy eating programme (FLS)
as well as use of the number of exercise sessions re-
corded in the exercise diary will be registered. The 6-
min walk test, stair test, and 30-s chair-stand test will
be administered by the PTs before and after the treat-
ment period. Test results are registered in the exer-
cise diary by the PT. In collaboration with the PT,
the participants fill in the Patient Specific Functional
Scale [43] by self-selecting between one and three activ-
ities that they are unable to do or have difficulty doing as
a result of their OA disease. The level of difficulty for each
activity is patient-reported before and after the treatment
period in the exercise diary using an 11-point numeric rat-
ing scale (0 = unable to perform activity, 10 = able to per-
form activity at pre-disease level).
GPs’ and PTs’ attendance at the workshops will be
registered. The GPs and PTs will respond to a
questionnaire immediately before and after the work-
shop as well as after 6 months. Telephone interviews
with estimated 10 % of the involved GPs and PTs will
be undertaken 6 months post-workshop regarding
whether they have implemented the SAMBA model
(i.e. referred to physiotherapy, arranged patient OA
education programmes, offered a supervised exercise
programme), their experiences with the implementa-
tion strategy, and reasons for eventual non-use of the
SAMBA model. Also, about 10 participants with hip
Table 2 Criteria for inclusion or exclusion
Inclusion criteria Exclusion criteria
• Males and females 45 years or older
• Activity-related hip and/or knee pain/complaints AND
• Clinical signs and symptoms corresponding to hip and/or knee OA
OR radiologically diagnosed OA OR registered in the medical
journal with the ICPC codes L89 (osteoarthritis of the hip), L90
(osteoarthritis of knee), and/or L91 Osteoarthritis (not classified
elsewhere).
• Total hip or knee replacement in the actual joint(s) and no pain/complaints
in the other hip or knee joint(s)
• Inflammatory rheumatic diseases (e.g. rheumatoid arthritis, spondyloarthritis)
• Malignant illness or other major conditions (i.e. unstable cardiovascular
disorders or lung disease, dementia) that restrict the ability to adhere to the
recommended OA treatment
• Do not understand the Norwegian language
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and/or knee OA will be telephone interviewed regard-
ing their experiences with the SAMBA model for in-
tegrated OA care. The interview data will be explored
by text analyses, coded, and combined into broad
categories.
Data collection
The participants with hip and/or knee OA will be asked
to complete electronic questionnaires via a link sent by
email. If a participant has no email address or internet
access or is reluctant to reply electronically, the
Table 3 Primary and secondary outcomes
Measurement scale Timea
Primary outcome measure (patient-reported)
OsteoArthritis Quality Indicator Questionnaire [20] 0–100 % (pass rate) 0, 3, 6, 9,12
Patient-reported secondary outcome measures
Pain level in hip/knee past week NRS 0–10 0, 3, 6, 9,12
Stiffness in the hip/knee past week NRS 0–10 —“—
Hip/knee function in the past week NRS 0–10 —“—
Patient global assessment of the OA disease NRS 0–10 —“—
Patient acceptable symptom state (PASS) Acceptable/
unacceptable
—“—
Function (Knee injury and Osteoarthritis Outcome Score
OoL subscale [44]/Hip disability and Osteoarthritis Outcome
Score OoL subscale [45] (K/HOOS)
4 items, 5-point scale —“—
Physical activity (frequency, intensity, duration) [47] 3 items —“—
Daily hours in sitting position 1 item —“—
Satisfaction with the care provided (from patient experience
questionnaires [48])
1 item, 5-point scale —“—
Health related quality of life (EQ-5D) [49] 5 items, 5-point scale —“—
Body weight kg —“—
Health care use past 3 months —“—
Patient Specific Functional Scale [43] NRS 0–10 Pre- and post exercise
programme
Adverse events 1 item Exercise diary
Measured patient secondary outcomes
30-s chair-stands test [50] Number of stands Pre- and post exercise
programme
6-min walk test [51] Metres —“—
Stairs test [52] Seconds —“—
GP- and PT-reported secondary outcome measures
Knowledge about recommended OA care 2 items, 5-point scale Pre- and post-workshop +
6 months post-workshop
Attitude towards OA treatment and recommendations 4 items, 5-point scale —“—
Behaviour in OA care (referrals, imaging) —“— —“—
Register based data secondary outcome measures
Number of referrals to secondary care that does not lead to
scheduled joint surgery
0–12
Number of referrals to MRI for OA assessment —“—
Number of GP referrals for OA patients to PTs at FLSs/private practice —“—
PTs at FLSs/in private practice secondary outcome measures
Number of discharge reports from PTs at FLSs/ private practice to
the referring GP
0–12
a0 = baseline assessment, the other numbers indicate months after baseline assessment
MRI magnetic resonance imaging, NRS numeric rating scale
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questionnaire and a prepaid envelope will be mailed to
the participant. Information on participant age, gender,
joint replacements, and comorbidity will be collected by
the project coordinators during the telephone screening.
Other participant characteristics and OA disease related
information will be self-reported at baseline (body
height, marital status, years of education, occupational
status, joints with OA, most affected joint, years with
OA diagnosis, and function (Knee injury and Osteoarth-
ritis Outcome Score/ Hip disability and Osteoarthritis
Outcome Score ADL subscale)). Demographic data on
the GPs and PTs will be collected at the workshop (age,
gender, years since graduation, speciality, type of prac-
tice, number of GPs/PTs in the practice, number of
weekly working hours, and number of people on the
GPs’ lists).
National register data
We will apply for permission to extract data on prescrip-
tion of medication, sick leave, secondary health care
utilization, and total joint surgery from national registers
(i.e. The Norwegian Prescription Database, the register
of The Norwegian Labour and Welfare Administration,
The Norwegian Patient Register, The Norwegian Arthro-
plasty Register) to merge with collected data after the
study has ended. Consent to data merging will be ob-
tained from the participants with hip and/or knee OA.
Cost-utility
Based on the findings in this study, two economic evalu-
ations will be conducted, applying both health system
and societal perspectives. Costs in the health care sector
comprise intervention costs and costs related to treat-
ment or assessments, while societal costs include pro-
duction loss, as well as costs for the individuals and the
family. The primary economic evaluation will be cost-
utility analysis (CUA) of the incremental cost per quality
adjusted life years (QALYs) gained, which will be calcu-
lated using the EQ-5D scores at baseline, 3, 6, 9 and
12 months. The secondary evaluation will be a cost-
effectiveness analysis (CEA) based on a disease-specific
measure of function: Knee injury and Osteoarthritis
Outcome Score OoL subscale [44]/ Hip disability and
Osteoarthritis Outcome Score OoL subscale [45] (K/
HOOS). Incremental cost per K/HOOS will be calcu-
lated as the ratio of the difference between groups in
mean cost to the difference in mean K/HOOS. By means
of bootstrapping, cost-effectiveness acceptability curves
(CEACs) will be used to consider the uncertainty sur-
rounding the cost-effectiveness of the integrated OA
care model by plotting the probability that the model is
cost-effective according to a range of willingness-to-pay
thresholds.
Statistical analyses
Baseline characteristics of the participants with OA,
the GPs, and the PTs will be presented for the total
study and stratified by cluster. Participant characte-
ristics will also be presented stratified by group allo-
cation. The primary effect analysis will be performed
on an intention to treat basis by comparing OA QI
summary pass rate in the control group vs. the inter-
vention group with the 6-month follow-up as the pri-
mary evaluation time point. Multilevel mixed-models
will be fitted to adjust for the effect of clustering
(municipality), participant (patient), and repeated
measures over time. Analyses of effect and process
outcomes in regression analyses will include the base-
line value of the outcome variable and be adjusted for
covariates at the individual patient participant level
(age, gender, education level, pain (NRS 0–10), BMI,
baseline function (K/HOOS ADL), self-reported co-
morbidity). To adjust for potential differences related
to GPs behaviour, we will include attendance at the
GP workshop as a covariate in analyses. A CACE
analysis will be performed to provide an unbiased es-
timate of treatment effect for participants treated as
per protocol specification (in the intervention group:
participants having attended the OA patient education
programme and performed an exercise programme
for at least 8 weeks).
Ethical approval
The Regional Committee for Medical and Health Re-
search Ethics decided that ethical approval was not
required under the Norwegian Act on medical and
health research for this type of study (ref. no: 2014/
1739 REK south-east C). The study is in accordance
with the Personal Data Act and the Personal Health
Data Filing System Act as approved by the Data In-
spectorate/Data Protection Official on December 22,
2014. The data collection will be conducted in com-
pliance with Good Clinical Practices protocol and the
Declaration of Helsinki principles. The participants
with OA will receive written and oral information
about the study, and written informed consents will
be obtained prior to baseline data collection.
Trial status
The preparation of the study components and the re-
cruitment of GPs and PTs were completed in December
2014. The SAMBA study data collection started in
January 2015 and is currently (October 2015) ongoing.
Discussion
This study aims to implement the SAMBA model for inte-
grated OA care aiming to improve professional practice
and patient outcomes and reduce non-desired events (e.g.
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unnecessary referrals to secondary care, unnecessary use
of costly imaging modalities, use of treatment modalities
supported by low quality of evidence). The model will be
implemented and evaluated in primary health care in six
municipalities in a stepped wedge cluster randomized
controlled trial.
This study represents a collaborative project includ-
ing six municipalities, one hospital department, and
two national research environments aiming to fulfil
the intentions of the Norwegian Health Care Coord-
ination Reform. [46] The new OA care model meets
the current need for a multidisciplinary approach to
manage people with chronic diseases and strengthen
the health care services through collaboration while
keeping the individual in focus. To ensure feasibility
and compliance both patient representatives, GPs and
PTs will be actively involved in the model develop-
ment and implementation. The study also includes
close collaboration with international experts, which
will contribute in the study and share relevant experi-
ences from similar implementation studies.
This large cluster stepped wedge randomized trial will
add to the current knowledge on structured approaches
aiming to improve the uptake of evidence-based OA
care recommendations in primary health care, which
may improve the quality of OA care. The study may pro-
vide new knowledge that can be used in national and
international implementation initiatives designed to im-
prove the quality of OA care.
Additional files
Additional file 1: The SAMBA model for integrated OA care.This file
contains a brief description of the development of the SAMBA model for
integrated OA care and the workshop training packages. The GP and PT
intervention is described more in detail, and the SAMBA model is
illustrated in a figure. (DOCX 32kb)
Additional file 2: Focus group interviews.This file contains the results
from three focus group interviews aiming to identify potential barriers
and facilitators for the SAMBA model implementation and the workshop
training packages. (DOCX 12kb)
Additional file 3: Brief overview of The SAMBA/ActiveA
physiotherapist workshop training package and the patient
management programme. This file contains an overview of the
SAMBA/ActiveA physiotherapist workshop training package and the
patient management program, which is illustrated in a model. Exercises
for improving neuromuscular control, muscle strength and range of
motion are illustrated. (DOCX 832kb)
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